Arrowstreet Capital’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-76,028
Closed -$7.01M – 1974
2025
Q4
$7.01M Buy
+76,028
New +$7.27M ﹤0.01% 1048
2025
Q1
– Sell
-35,294
Closed -$6.54M – 1902
2024
Q4
$6.54M Buy
35,294
+33,202
+1,587% +$6.44M 0.01% 934
2024
Q3
$442K Buy
+2,092
New +$363K ﹤0.01% 1533
2023
Q4
– Sell
-38,738
Closed -$7.69M – 1477
2023
Q3
$7.69M Buy
38,738
+550
+1% +$139K 0.01% 576
2023
Q2
$12.4M Buy
38,188
+26,298
+221% +$7.51M 0.02% 468
2023
Q1
$2.78M Sell
11,890
-11,581
-49% -$2.93M ﹤0.01% 840
2022
Q4
$5.91M Sell
23,471
-5,194
-18% -$1.11M 0.01% 638
2022
Q3
$5.08M Buy
+28,665
New +$5.76M 0.01% 651
2022
Q1
– Sell
-9,825
Closed -$2.26M – 1366
2021
Q4
$2.26M Sell
9,825
-3,992
-29% -$975K ﹤0.01% 985
2021
Q3
$3.22M Buy
13,817
+10,500
+317% +$2.19M ﹤0.01% 1042
2021
Q2
$641K Sell
3,317
-63,072
-95% -$12.5M ﹤0.01% 1641
2021
Q1
$13.7M Buy
66,389
+4,198
+7% +$892K 0.02% 739
2020
Q4
$11.7M Buy
+62,191
New +$10.2M 0.02% 817

Other funds holding INSP

Arrowstreet Capital's INSP Position: Q1 2026 in Review

Arrowstreet Capital sold out of Inspire Medical Systems (INSP) in Q1 2026, closing a stake of 76,028 shares — an estimated $7.01M sold.

Arrowstreet Capital first reported a position in INSP in Q4 2020 and held it in 13 quarters. The position peaked at $13.7M in Q1 2021. 301 funds tracked by Wall St. Rank hold INSP as of Q1 2026.

  • Arrowstreet Capital reported no remaining Inspire Medical Systems position as of Q1 2026 after selling out during the quarter.
  • Arrowstreet Capital sold 76,028 Inspire Medical Systems shares in Q1 2026, an estimated $7.01M.
  • Arrowstreet Capital first reported a position in Inspire Medical Systems in Q4 2020 and held it in 13 quarters.
  • Arrowstreet Capital's Inspire Medical Systems position peaked at $13.7M in Q1 2021.
  • 301 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q1 2026.

Based on Arrowstreet Capital's 13F filing for Q1 2026, filed 14 May 2026.